Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations
This single-center, single-arm quasi-experimental study will assess the feasibility and
acceptability of a community health worker (CHW)-led intervention to address social
determinants of health (SDOH) among emergency department patients with hypertension. At
enrollm...
Age: 18 years - 66+
Gender: All
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
The goal of this clinical study is to evaluate the safety and efficacy of percutaneous
pulmonary artery denervation with the Multi-Pole Pulmonary Artery Radiofrequency Ablation
Enhancor System in patients with combined pre- and post-capillary pulmonary hypertension
(...
Age: 18 - 85 years
Gender: All
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target
with stability within 60 minutes of enrollment, among patients treated with IV
clevidipine with those treated with alternate IV antihypertensive regimen.
Age: 18 - 100 years
Gender: All
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
The purpose of the study is to learn how the study medicine called PF-07868489 is
tolerated and acts in healthy adult people and people with pulmonary arterial
hypertension (PAH).
Part A:
An investigator- and participant-blind, sponsor-open, placebo-controlled, ...
Age: 18 - 65 years
Gender: All
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A prospective, multinational, randomized, double-blind, clinical trial evaluating the
safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm
downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Age: 18 years - 66+
Gender: All
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the
Efficacy and Safety of LAM-001 in Adults with Pulmonary Hypertension Associated with
Interstitial Lung Disease (PH-ILD).
Age: 18 - 80 years
Gender: All
Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms
The goal of the parent R01 study has been to determine how beliefs about chronic illness and their treatments affect SMB in the context of chronic obstructive pulmonary disease (COPD) with comorbid hypertension (HTN) and or diabetes (DM). The educational counseling modu...
Age: Birth - 66+
Gender: All
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
This study is a prospective Phase IV study to determine if the use of Everolimus results
in lower liver tumor recurrence and improved patient and graft survival after liver
transplant for hepatocellular carcinoma (HCC). The immunosuppressive comparators will be
Evero...
Age: 18 years - 66+
Gender: All